![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print August 26, 2004
Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio 44106-4935
Corresponding Author: dsamols{at}cwru.edu
C-reactive protein (CRP) is a phylogenetically highly conserved plasma protein, with homologs in vertebrates and many invertebrates, that participates in the systemic response to inflammation. Its plasma concentration increases during inflammatory states, a characteristic that has long been employed for clinical purposes. CRP is a pattern recognition molecule, binding to specific molecular configurations that are typically exposed during cell death or found on the surfaces of pathogens. Its rapid increase in synthesis within hours after tissue injury or infection suggests that it contributes to host defense, and that it is part of the innate immune response. Recently, an association between minor CRP elevation and future major cardiovascular events has been recognized, leading to the recommendation by the Centers for Disease Control and the American Heart Association that patients at intermediate risk of coronary heart disease might benefit from measurement of CRP. This review will largely focus on our current understanding of the structure of CRP, its ligands, the effector molecules with which it interacts, and its apparent functions.
J. Biol. Chem, 10.1074/jbc.R400025200
Submitted on July 27, 2004
Revised on August 17, 2004
Accepted on August 26, 2004
C-reactive protein
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. P. Young, I. Kushner, and D. Samols Binding of C/EBP{beta} to the C-Reactive Protein (CRP) Promoter in Hep3B Cells Is Associated with Transcription of CRP mRNA J. Immunol., August 15, 2008; 181(4): 2420 - 2427. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Falk, O. A. Minai, and Z. Mosenifar Inhaled and Systemic Corticosteroids in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, May 1, 2008; 5(4): 506 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Falk, S. Kadiev, G. J. Criner, S. M. Scharf, O. A. Minai, and P. Diaz Cardiac Disease in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, May 1, 2008; 5(4): 543 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Joaquin, E Aguilera, M L Granada, M C Pastor, I Salinas, N Alonso, and A Sanmarti Effects of GH treatment in GH-deficient adults on adiponectin, leptin and pregnancy-associated plasma protein-A. Eur. J. Endocrinol., April 1, 2008; 158(4): 483 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nishikawa, K. Hagihara, S. Serada, T. Isobe, A. Matsumura, J. Song, T. Tanaka, I. Kawase, T. Naka, and K. Yoshizaki Transcriptional Complex Formation of c-Fos, STAT3, and Hepatocyte NF-1{alpha} Is Essential for Cytokine-Driven C-Reactive Protein Gene Expression J. Immunol., March 1, 2008; 180(5): 3492 - 3501. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Van Vre, H. Bult, V. Y. Hoymans, V. F.I. Van Tendeloo, C. J. Vrints, and J. M. Bosmans Human C-Reactive Protein Activates Monocyte-Derived Dendritic Cells and Induces Dendritic Cell-Mediated T-Cell Activation Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 511 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim, T. O. Keku, C. Martin, J. Galanko, J. T. Woosley, J. C. Schroeder, J. A. Satia, S. Halabi, and R. S. Sandler Circulating Levels of Inflammatory Cytokines and Risk of Colorectal Adenomas Cancer Res., January 1, 2008; 68(1): 323 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schmid, A. Schneitter, S. Hinterberger, J. Seeber, A. Reinthaller, and L. Hefler Association of Elevated C-reactive Protein Levels With an Impaired Prognosis in Patients With Surgically Treated Endometrial Cancer Obstet. Gynecol., December 1, 2007; 110(6): 1231 - 1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lithgow, A. Nyamathi, D. Elashoff, O. Martinez-Maza, and C. Covington C-reactive Protein in Nipple Aspirate Fluid Associated With Gail Model Factors Biol Res Nurs, October 1, 2007; 9(2): 108 - 116. [Abstract] [PDF] |
||||
![]() |
A. Stavropoulos-Kalinoglou, G. S Metsios, Y. Koutedakis, A. M Nevill, K. M Douglas, A. Jamurtas, J. J C S V. van Zanten, M. Labib, and G. D Kitas Redefining overweight and obesity in rheumatoid arthritis patients Ann Rheum Dis, October 1, 2007; 66(10): 1316 - 1321. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liu, L. Tinker, Y. Song, N. Rifai, D. E. Bonds, N. R. Cook, G. Heiss, B. V. Howard, G. S. Hotamisligil, F. B. Hu, et al. A Prospective Study of Inflammatory Cytokines and Diabetes Mellitus in a Multiethnic Cohort of Postmenopausal Women Arch Intern Med, August 13, 2007; 167(15): 1676 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schwartz, S. Osborne-Lawrence, L. Hahner, L. L. Gibson, A. K. Gormley, W. Vongpatanasin, W. Zhu, R. A. Word, D. Seetharam, S. Black, et al. C-Reactive Protein Downregulates Endothelial NO Synthase and Attenuates Reendothelialization In Vivo in Mice Circ. Res., May 25, 2007; 100(10): 1452 - 1459. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Song, T. Y Li, R. M van Dam, J. E Manson, and F. B Hu Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women Am. J. Clinical Nutrition, April 1, 2007; 85(4): 1068 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rocker, D. E. Manolov, E. V. Kuzmenkina, K. Tron, H. Slatosch, J. Torzewski, and G. U. Nienhaus Affinity of C-Reactive Protein toward Fc{gamma}RI Is Strongly Enhanced by the {gamma}-Chain Am. J. Pathol., February 1, 2007; 170(2): 755 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Rodriguez, C. Mold, M. Kataranovski, J. A. Hutt, L. L. Marnell, J. S. Verbeek, and T. W. Du Clos C-Reactive Protein-Mediated Suppression of Nephrotoxic Nephritis: Role of Macrophages, Complement, and Fc{gamma} Receptors J. Immunol., January 1, 2007; 178(1): 530 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Crawford, C. L. Sanders, X. Qin, J. D. Smith, C. Shephard, M. Wong, L. Witrak, M. J. Rieder, and D. A. Nickerson Genetic Variation Is Associated With C-Reactive Protein Levels in the Third National Health and Nutrition Examination Survey Circulation, December 5, 2006; 114(23): 2458 - 2465. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Johnson, K. E. Betts, M. J. Radeke, G. S. Hageman, D. H. Anderson, and L. V. Johnson Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid PNAS, November 14, 2006; 103(46): 17456 - 17461. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhou, Y. P. Jang, S. R. Kim, and J. R. Sparrow Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium PNAS, October 31, 2006; 103(44): 16182 - 16187. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Marsik, R. Sunder-Plassmann, B. Jilma, F. M. Kovar, C. Mannhalter, O. Wagner, H. Rumpold, and G. Endler The C-Reactive Protein +1444C/T Alteration Modulates the Inflammation and Coagulation Response in Human Endotoxemia Clin. Chem., October 1, 2006; 52(10): 1952 - 1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. He, L. W. Shepard, J. Chen, Z. K. Pan, and R. D. Ye Serum Amyloid A Is an Endogenous Ligand That Differentially Induces IL-12 and IL-23 J. Immunol., September 15, 2006; 177(6): 4072 - 4079. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Sacheck, J. G. Cannon, K. Hamada, E. Vannier, J. B. Blumberg, and R. Roubenoff Age-related loss of associations between acute exercise-induced IL-6 and oxidative stress Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E340 - E349. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. G. Despriet, C. C. W. Klaver, J. C. M. Witteman, A. A. B. Bergen, I. Kardys, M. P. M. de Maat, S. S. Boekhoorn, J. R. Vingerling, A. Hofman, B. A. Oostra, et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA, July 19, 2006; 296(3): 301 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Paffen and M. P.M. deMaat C-reactive protein in atherosclerosis: A causal factor? Cardiovasc Res, July 1, 2006; 71(1): 30 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Sjoberg, L. A. Trouw, F. D. G. McGrath, C. E. Hack, and A. M. Blom Regulation of complement activation by C-reactive protein: targeting of the inhibitory activity of c4b-binding protein. J. Immunol., June 15, 2006; 176(12): 7612 - 7620. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kardys, M. P.M. de Maat, A. G. Uitterlinden, A. Hofman, and J. C.M. Witteman C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study Eur. Heart J., June 1, 2006; 27(11): 1331 - 1337. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mineo and P. W. Shaul Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae Cardiovasc Res, April 1, 2006; 70(1): 31 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mazziotti, G. Amato, F. Sorvillo, M. Piscopo, M. R. Rizzo, E. Lalli, L. Iride, M. Cioffi, A. M. Molinari, G. Paolisso, et al. Increased serum osteoprotegerin values in long-lived subjects: different effects of inflammation and bone metabolism. Eur. J. Endocrinol., March 1, 2006; 154(3): 373 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aviv, A. Valdes, J. P. Gardner, R. Swaminathan, M. Kimura, and T. D. Spector Menopause Modifies the Association of Leukocyte Telomere Length with Insulin Resistance and Inflammation J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 635 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Bodnar, R. B. Ness, G. F. Harger, and J. M. Roberts Inflammation and Triglycerides Partially Mediate the Effect of Prepregnancy Body Mass Index on the Risk of Preeclampsia Am. J. Epidemiol., December 15, 2005; 162(12): 1198 - 1206. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mineo, A. K. Gormley, I. S. Yuhanna, S. Osborne-Lawrence, L. L. Gibson, L. Hahner, R. V. Shohet, S. Black, J. E. Salmon, D. Samols, et al. Fc{gamma}RIIB Mediates C-Reactive Protein Inhibition of Endothelial NO Synthase Circ. Res., November 25, 2005; 97(11): 1124 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Weitkamp and J. L. Aschner Diagnostic Use of C-Reactive Protein (CRP) in Assessment of Neonatal Sepsis NeoReviews, November 1, 2005; 6(11): e508 - e515. [Full Text] [PDF] |
||||
![]() |
H. Sun, T. Koike, T. Ichikawa, K. Hatakeyama, M. Shiomi, B. Zhang, S. Kitajima, M. Morimoto, T. Watanabe, Y. Asada, et al. C-Reactive Protein in Atherosclerotic Lesions: Its Origin and Pathophysiological Significance Am. J. Pathol., October 1, 2005; 167(4): 1139 - 1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Khreiss, L. Jozsef, L. A. Potempa, and J. G. Filep Loss of Pentameric Symmetry in C-Reactive Protein Induces Interleukin-8 Secretion Through Peroxynitrite Signaling in Human Neutrophils Circ. Res., September 30, 2005; 97(7): 690 - 697. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Devaraj, G. O'Keefe, and I. Jialal Defining the Proinflammatory Phenotype Using High Sensitive C-Reactive Protein Levels as the Biomarker J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4549 - 4554. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Weatherill, J. Y. Lee, L. Zhao, D. G. Lemay, H. S. Youn, and D. H. Hwang Saturated and Polyunsaturated Fatty Acids Reciprocally Modulate Dendritic Cell Functions Mediated through TLR4 J. Immunol., May 1, 2005; 174(9): 5390 - 5397. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Venugopal, S. Devaraj, and I. Jialal Macrophage Conditioned Medium Induces the Expression of C-Reactive Protein in Human Aortic Endothelial Cells: Potential for Paracrine/Autocrine Effects Am. J. Pathol., April 1, 2005; 166(4): 1265 - 1271. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |